Original language | English (US) |
---|---|
Pages (from-to) | e364-e367 |
Journal | Haemophilia |
Volume | 25 |
Issue number | 6 |
DOIs | |
State | Published - Nov 1 2019 |
All Science Journal Classification (ASJC) codes
- Hematology
- Genetics(clinical)
Access to Document
Other files and links
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver
}
In: Haemophilia, Vol. 25, No. 6, 01.11.2019, p. e364-e367.
Research output: Contribution to journal › Letter › peer-review
TY - JOUR
T1 - Pharmacokinetics of a new human plasma-derived double virus inactivated and nanofiltered factor IX concentrate in previously treated severe or moderately severe haemophilia B patients
AU - Castaman, Giancarlo
AU - Borchiellini, Alessandra
AU - Santagostino, Elena
AU - Tagariello, Giuseppe
AU - Serban, Margit
AU - Uscatescu, Marusia
AU - Truica, Cristina
AU - Farrugia, Albert
AU - Morfini, Massimo
N1 - Funding Information: BA: Advisory board or speaker fee for Bayer, CSL Behring, Roche, Kedrion, Grifols, Novo Nordisk, Sobi, Pfizer. CG: Advisory Board or speaker Kedrion, Novo Nordisk, SOBI, Bayer, Shire, Pfizer, CSL Behring. Grant support directly to Institution from Pfizer and CSL Behring Fasulo MR. is employed by Bayer Guarnieri C. and Macchia R. are employed by Kedrion Biopharma. MME: consultant and/or speaker fees for Bayer Healthcare, Baxalta/Shire, Biotest, CSL Behring, Novo Nordisk, Octapharma, Pfizer, Roche, and Sobi/Biogen Idec. MM: paid consultant to Bayer, Baxter, Novo Nordisk, Pfizer Advisory Boards. A fee as an invited speaker at CSL Behring Symposia, Biotest, Bayer, Kedrion, Novo Nordisk, SOBI and Octapharma. Research grants from Bayer, Pfizer, and Baxter. SE: Advisory board and/or Speaker Bureau for the Shire, Bayer, CSL Behring, Grifols, Kedrion, Novo Nordisk, Octapharma, Pfizer, Roche, Biogen, and Sobi. SM: Advisory board or speaker for Novo‐Nordisk and Shire; research grant from Novo‐Nordisk and Pfizer. FA: compensated consultancy to manufacturers of coagulation factor concentrates Aksu S., Radossi P., Serban M., Tagariello G., Paladino E., Truica C., Uscatescu V., and Valpreda A. have disclosed no conflicts of interest.
PY - 2019/11/1
Y1 - 2019/11/1
UR - http://www.scopus.com/inward/record.url?scp=85072176071&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85072176071&partnerID=8YFLogxK
U2 - 10.1111/hae.13828
DO - 10.1111/hae.13828
M3 - Letter
C2 - 31509326
AN - SCOPUS:85072176071
SN - 1351-8216
VL - 25
SP - e364-e367
JO - Haemophilia
JF - Haemophilia
IS - 6
ER -